InvestorsHub Logo
Followers 36
Posts 1166
Boards Moderated 0
Alias Born 03/07/2013

Re: LaddyMan post# 29817

Monday, 10/24/2016 12:00:33 PM

Monday, October 24, 2016 12:00:33 PM

Post# of 118421
LaddyMan,

Yes, I noticed the same.

What is lacking from today's PR is any vision of the future. No mention of ongoing collaboration, no news about what Pan Am treatment center is planning on doing in the future.

Are they stopping after 5 successful patients? If so why? Are they planning a more expansive trial? If so, why not tell us?

Has RGBP submitted an expanded IND with FDA yet as they told us they were planning to have approval for in 4th Qtr? If not, when?

Because they don't put the good news into any context of future progress/development (if there is to be any), the PRs lack any depth of creating movement or significant interest in the company. We have bits and pieces of success with no news as to any concrete time line development that can be expected.

Sure would be nice to know if any future human trials are planned by Pan Am treatment center and to where this successful trial results leads us.

The fact that RGBP downplays the results and not being able to know effectiveness of HemaX while in other PRs talking up the future potential of other pipeline products is not a good sign.